Meeting Coverage:

Retina World Congress Meeting

RWC: 2017

Anti-VEGF Therapy and Vitrectomy in Severe PDR

Show Description +

J. Fernando Arevalo, MD, summarizes his discussion on time from intravitreal bevacizumab (Avastin, Genentech) injection to vitrectomy in cases of severe proliferative diabetic retinopathy (PDR). He provides important data from his group's collaboration with other groups.

Posted: 1/25/2017

Anti-VEGF Therapy and Vitrectomy in Severe PDR

J. Fernando Arevalo, MD, summarizes his discussion on time from intravitreal bevacizumab (Avastin, Genentech) injection to vitrectomy in cases of severe proliferative diabetic retinopathy (PDR). He provides important data from his group's collaboration with other groups.

Posted: 1/25/2017


Please log in to leave a comment.

More From RWC: 2017 Coverage

Abicipar Pegol in Phase 2

Pravin Dugel, MD

OCTA in DR

Nadia Waheed, MD

Managing TRDs

Maria H. Berrocal, MD